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www.elsevier.com/locate/inextA 26-year-old male with documented SCD (Hgb SS)
presented to the Emergency Department with multi-
ple gun shot wounds. The patient had bullet wounds
in the left lower quadrant and the left flank aswell as
two wounds to the left upper extremity (with an
obvious deformity) and a single wound to the right
lower extremity (with the bullet palpable in the
subcutaneous tissue). The patient was in distress,
tachycardic, diaphoretic with a rigid abdomen. A
chest roentegram was reported as being normal,
following which, an exploratory laparotomy was per-
formed. Findings at laparotomy were four perforat-
ing small bowel injuries with a small serosal tear in
the left colon. A small bowel resection (including all
four injuries and comprising of 50 cm of proximal
ileum)with primary anastomosis was performed. The
colonic serosal injury was also oversewn. Total esti-
mated blood loss was 300 cm3. The patient was
haemodynamically stable throughout the case with
good urine output. An intraoperative arterial blood* Corresponding author. Tel.: +1 617 414 5689;
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Open access under the Elsevier OA license. gaswas performed andwas unremarkable. An intrao-
perative CBC was notable for a leucocytosis of 24 K/
UL and aHct of 36%. This procedurewas followedby a
washout of the left upper extremity wound for a
comminuted ulnar fracture.
The patient was extubated post op and trans-
ferred to the PACU where he remained stable. He
was admitted to a regular surgical floor, where his
post op care was relatively standard. He was placed
on an isotonic fluid initially with a narcotic patient
controlled analgesia (PCA) for pain. Over the first
12 h his post-operative course was uneventful. At
the initial post op check the patient’s vital signs
were stable. His pain score was noted to be 5/10. He
had acceptable urine output and his nasogastric
tube was functioning well. A post op CBC revealed
a WBC of 24 K/UL and a Hct of 34%. Approximately
4 h later, the patient was assessed by the surgical
team. He was, again, relatively comfortable (pain
5/10) with stable vitals. However, in approximately
6 h the patient was complaining of 10/10 incisional
pain, as well as chest pain. He also had severe
extremity wound pain. His blood pressure was
recorded as 78/50 mmHg with a pulse of 145 bpm
and he had a low-grade fever of 100.9 F. An ABG
revealed a pH of 7.04, PCO2 of 58 mmHg, PO2 of
50 mmHg and a HCO3 of 15 mmol/L. Haemoglobin
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reported at 66 K/UL with a reticulocyte count of
9.0% (0.6-2.6%). A chest roentegram was performed
and revealed diffuse bilateral infiltrates.
The patient was transferred to the SICU and
intubated. Shortly thereafter, his abdomen became
markedly distended with decreased urine output.
His peak airway and bladder pressures were also
markedly elevated–—consistent with acute abdom-
inal compartment syndrome. Hewas taken to the OR
for an emergent laparotomy. Findings were signifi-
cant for 3 l of blood in the peritoneal cavity. No
surgical bleeding was identified. He was washed out
and fibrin glue was placed in the left paracolic
gutter (the left colon had been partially mobilized
at initial laparotomy).
Perioperatively, the patient received 13 units of
PRBCs, 9 units of FFP, 4 packs of platelets, and 2 pools
of cryoprecipitate. Following haematology consulta-
tion, the patient also underwent an exchange trans-
fusion. Haemoglobin S levelswere 18% and7% prior to
and following exchange transfusion, respectively.
During the first 24 h following his admission to the
SICU this patient had significant elevations in the his
liver enzymes, muscle enzymes and renal function
parameters–—total bilirubin of 14 mg/DL, direct bilir-
ubin of 7.7 mg/DL, AST 5700 U/L, ALT 1050 U/L, CKs
peaking at 13,000 U/L, BUN/creatinine 91/6.2 mg/
DL, and potassium > 7.5 mmol/L.
The patient had a long complicated ICU course
with multisystem organ failure. He ultimately
underwent tracheostomy and required enteral
access. One of the other very notable aspects of
his hospital course was the significant myonecrosis
(and associated rhabdomyolysis) of his two extre-
mity wounds. This patient required a number of
operations for repeated washouts and debridements
of these wounds. In each case his CKs rose signifi-
cantly with concomitant elevations in potassium,
BUN and creatinine. This myonecrosis of his extre-
mities resulted in severe morbidity–—at the time of
discharge he had extremely limited function of
these extremities. He remained as an inpatient
for over 1 month before he was ultimately dis-
charged to a rehabilitation facility.Discussion/review of the literature
Sickle cell disease is a hereditary haemoglobinopathy
resulting from the inheritance of a mutant version of
the b-globin gene on chromosome 11, the gene cod-
ing for theb-globin chainsof theproteinhaemoglobin
A (a2b2). Individuals with this mutation have resul-
tant defective haemoglobin S. Patients with SCD
typically are homozygous for the abnormal b-globingene (a2bs2) (although there are other genotypes
such as SC disease and S-beta-thalassemia). Deoxy-
genation of haemoglobin S leads to intracellular
polymerization and distortion of the red blood cell
(RBC) into the classic sickle shape. The major con-
sequence of this sickle shape is that RBCs become
much less deformable and obstruct themicrocircula-
tion. Tissue hypoxia, which promotes further sick-
ling, results. The clinical hallmark of this process is
the vasoocclusive crisis, causing ischemic injury to
the organ supplied. Pain is the most frequent com-
plaint during these episodes, and it is ischemic in
origin.Thismayessentially involveanyorgan, leading
to a variety of systemic problems.
Some of the notable clinical sequelae seen in SCD
relevant to this case are acute chest syndrome,
myonecrosis and multisystem organ failure. Acute
chest syndrome is an acute pneumonia-like compli-
cation of SCD, which is typically defined by fever, a
new infiltrate on chest X-ray, along with chest pain,
hypoxemia and respiratory distress.5 Precipitating
factors for acute chest syndrome include infection,
fat embolism and surgery. Although the involvement
of muscle and fascia is not often recognized as a
complication seen sickle cell crisis, myonecrosis
(and myofibrosis) has been clearly documented in
the literature.4 The pathogenesis is, again, rooted in
vascular occlusion.
Acute multiorgan failure has been documented in
the literature as a catastrophic complication of
sickle cell crises.3 The hallmarks of this complica-
tion include pain, which is unusually severe for the
patient, and rapid declines in the haemoglobin and
platelet counts. Relevant to this case, there is an
association with rhabdomyolysis. In a report that
characterized acute multisystem organ failure seen
in sickle cell patients, there were objective criteria
given to define dysfunction of the pulmonary, hepa-
tic and renal systems. Our patient clearly met these
criteria for all three systems.
Our patient developed many associated compli-
cations of SCD during his prolonged hospital course.
It is critical to consider what might have been done
differently during the first 24 h of the patient’s
course that may have prevented the development
of some of these complications. Aggressive hydra-
tion and meticulous pain control in sickle cell
patients are always paramount in preventing crisis.
In reviewing the literature there is significant evi-
dence to support the practice of simple periopera-
tive transfusions in sickle cell patients undergoing
elective abdominal procedures such as cholecys-
tectomy or splenectomy.6,7 Although the perfor-
mance of routine exchange transfusions for larger
surgical procedures (such as hip arthroplasty) has
been documented, this practice remains controver-
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to stratify surgical risk categories into low, medium
and high (based on the nature of the procedure) in
order to determine the subset of SCD patients who
would more clearly benefit from preemptive trans-
fusions.1
In dealing with trauma and emergency surgery in
sickle cell patients there is a paucity of precedents or
guidelines in the literature. In general, a multidisci-
plinary approach to these patients is critical.3 Cer-
tainly, earlier involvement of the haematologic team
(with closer and more specific monitoring of haema-
tologic parameters) should have been exercised. A
more detailed perioperative discussion with the
anaesthesia team with more aggressive pain control
and closer monitoring of oxygenation and acid—base
status in an ICU setting would also have been bene-
ficial.2 Our patient required an extensive open
abdominal procedure and suffered two significant
extremitywounds. According to the risk stratification
scheme mentioned above, he clearly would have
been categorized as high risk. More aggressive blood
transfusions in our patient early in perioperative
period might have averted the development of some
of the severe sickling complications from which he
suffered. Lastly, exquisite haemostasis with proac-
tive recognition of potential sites of haemorrhage in
areas such as the retroperitoneum and all raw sur-
faces should have been exercised.
There have been small, randomized trials using
inhaled nitric oxide (NO) in sickle cell patients.
These studies are based on the principle that the
vasoocclusive crises in sickle cell patients are asso-
ciated with abnormal nitric oxide-dependent regu-
lation of vascular tone.2 They showed improved paincontrol, fewer vasoocclusive crises and decreased
length of stay in the NO treated patients (as com-
pared to controls).8 This certainly has implications
in the treatment of sickle cell patients in a variety of
clinical circumstances. Indeed, this case highlights
the need to reevaluate and update the armamen-
tarium we, as surgeons, have in treating sickle cell
patients–—particularly in the setting of trauma and
emergency surgery.References
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